Dow Water & Process Solutions Separation and Purification Solutions, Ion Exchange Excipients and Ion Exchange APIs

Dow Water & Process Solutions

Dow Water & Process Solutions helps fuel the development of today’s most promising drugs and therapies. With more than 50 years of experience in the industry, Dow innovation helps pharmaceutical companies increase their value and market relevance with products and technologies that support speed to market, increase flexibility and drive new formulations.

In pharmaceuticals, Dow Water & Process Solutions specializes in providing technology and products in three key areas: purification / separation technology for bioprocessing, functional excipients for formulation and active pharmaceutical ingredients (API).

  • Dow ion exchange resins, chromatographic media and nanofiltration elements improve flexibility and efficiency in the critical separation and purification steps of drug manufacturing
  • Dow’s functional excipients are used by formulators in five key areas: taste masking, controlled and modified release, abuse deterrence, solubility and stability
  • For more than 20 years, Dow has been manufacturing the active ingredients to treat hyperkalemia (excessive potassium in the bloodstream) and hypercholesterolemia (excessive cholesterol in the bloodstream)

High-value separation and purification solutions for biopharmaceutical manufacturers

Dow Water & Process Solutions identifies, develops and offers high-value separation and purification solutions to biopharmaceutical manufacturers, helping them to achieve a higher degree of flexibility and efficiency in downstream processing. Dow’s high-quality production capabilities and decades of technical and regulatory expertise help offer customers with reliably consistent products and support that they can rely on for their manufacturing processes.

Dow provides expert technical service support for applications ranging from chromatographic separations to manufacturing process improvements. These cover all phases of biopharmaceutical downstream processing, from initial capture to purification and final polishing.

Dow demonstrates its innovation in bioprocessing through such breakthrough new products as the uniform particle size strong cation, AMBERCHROM HPS60. A more rigid resin for higher titers and improved selectivity and throughput, AMBERCHROM HPS60 helps manufacturers to decrease development time by offering a wide processing operating window. As manufacturers struggle with standardization and production pressures, innovative media such as AMBERCHROM HPS60 delivers exceptional performance.

Functional ion exchange excipients for improved drug delivery

Functional ion exchange excipients are the unsung heroes of drug formulation. Over several decades, Dow has built a broad portfolio of functional excipient technologies, based on ion exchange resins, to help improve the delivery of drugs and support ever-challenging industry needs. These functional excipients provide formulation flexibility in five key areas:

  1. Taste masking
  2. Controlled release
  3. Abuse deterrence
  4. Solubility
  5. Stability

Ion exchange functional excipients offer a proven, safe technology to solve difficult formulation problems to help drug companies to enhance product functionality, extend patent life and improve patient compliance.

Clinical expectations for controlled-release medications are evolving rapidly. Patients and doctors are looking to streamline drug regimens without compromising safety and effectiveness. Scientists, researchers and pharmaceutical partners work with Dow to design new formulations that help balance these imperatives. Our innovations may lead to healthier lives: drug delivery effectiveness can make the difference to the health and quality of a patient’s life. Whether minimizing the number of daily dosages, effectively controlling medication release, or taste masking a bitter drug, Dow functional excipient technologies help patients gain better control of their health.

A 20-plus year history in ion exchange APIs

For more than two decades, Dow’s active pharmaceutical ingredient (API) ion-exchange resins have proven an especially valuable treatment, as they help produce measurable and vital results without any harmful side effects to the patient. Dow supplies two APIs: cholestyramine and polystyrene sulfonate (PPS), used respectively in medicines to treat high cholesterol and high potassium, a common condition in renal failure.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

Dow Releases Three White Papers

Dow Water & Process Solutions has releases three white papers available to download in Pharmaceutical-technology.com.

White Papers

World-Class Solutions, Worldwide Impact

In every corner of the globe, from developing countries to the most advanced industrialised nations, Dow Water & Process Solutions is having a clear impact.

Dow Water & Process Solutions Images

Products and Services

Video

Press Release

30 August 2013

Dow Water & Process Solutions has releases three white papers available to download in Pharmaceutical-technology.com.

Read more
8 July 2013

Dow Water Process & Solutions (DW™PS) has received the top prize honour of 'Market Choice' for the new DOW FILMTEC™ ECO Reverse Osmosis (RO) elements in a product contest held by the Aquatech China committee and dayuu.com, an online water industry network.

Read more
4 June 2013

Dow Water & Process Solutions (DW&PS) today globally introduced DOW FILMTEC™ ECO Reverse Osmosis (RO) elements at Aquatech China 2013.

Read more
4 June 2013

Today at Aquatech China 2013, Dow Water & Process Solutions (DW&PS) launched its latest ultrafiltration (UF) innovation with a new efficient module design that is intended to provide high-quality water while reducing overall system costs.

Read more
16 April 2013

Learn more about how The Dow Chemical Company ('Dow') is collaborating with formulators, pharmaceutical companies, distributors and industry experts to help develop the next generation of ingredients and solutions to make the world healthier at Excipient Fest Americas.

Read more
1 April 2013

Today at the WQA Aquatech USA show announced the opening of a commercial-scale manufacturing facility for the TEQUATIC™ PLUS fine particle filter in Menlo Park, CA, that is designed to meet growing demand for its line of F-50, F-75 and F-150 models.

Read more
1 April 2013

The TEQUATIC™ PLUS F-50 fine particle filter from Dow Water & Process Solutions (DW&PS) is a winner of the 'Infinite Possibility for Market Growth Award' by the Awards for Composites Excellence (ACE) programme.

Read more
10 January 2013

Dow Water & Process Solutions (DW&PS), a business unit of The Dow Chemical Company (NYSE:DOW), announced today the commencement of its cooperation with Haier to supply the latter its advanced FILMTEC™ Reverse Osmosis (RO) technology applied in its residential water purification system and filtration products.

Read more

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.